Danaher Corp., US2358511028

Danaher stock reports USD 6.26 billion Q2 revenue ahead of earnings

Published on 09/29/2026 at 13:24 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWS

Danaher stock delivered adjusted EPS of USD 1.94 against USD 1.85 consensus in Q2/2026. The next results call is scheduled for October 21, 2026.

Schwarz-Weiß-Reportagefoto eines Forschers am Mikroskop in einem klassischen Diagnostiklabor
Danaher Corp. Diagnostik-Labor US2358511028 in dokumentarischer Schwarzweiß-Reportage mit Forscher am alten Mikroskop, Illustration mit AI erstellt.

Danaher Corporation (ISIN US2358511028) was trading at EUR 199.23 at Lang & Schwarz on September 29, 2026 at 1:20 p.m. CEST, down 0.04 percent versus the EUR 199.30 prior close. The stock's key question now is whether its latest earnings beat can support the next stage of growth.

Goldman target reaches USD 250.00

According to MarketBeat on September 24, 2026, Goldman Sachs raised its Danaher price target from USD 210.00 to USD 250.00 and maintained a buy rating. The move places the analyst target above the USD 227.42 NYSE quote last reported for September 28, 2026 at 4:00 p.m. ET.

Q2 revenue rises 5.5 percent

For Q2/2026, MarketBeat reported adjusted EPS of USD 1.94 against USD 1.85 consensus, a USD 0.09 beat. Revenue reached USD 6.26 billion, up 5.5 percent from the prior-year quarter and above the USD 6.12 billion consensus.

The result gives investors two separate signals: earnings conversion exceeded expectations, while the revenue increase remained measurable rather than purely acquisition-driven in the reported comparison. Danaher's portfolio spans biotechnology, diagnostics and life sciences, including tools used in biopharmaceutical research and clinical testing.

Next results arrive October 21

Danaher scheduled its Q3/2026 earnings conference call for October 21, 2026, beginning at 8:00 a.m. ET. That date is the next concrete checkpoint for testing whether the Q2 revenue growth rate and earnings performance are continuing.

Euro quote edges lower

At Lang & Schwarz, Danaher stock stood at EUR 199.23 on September 29, 2026 at 1:20 p.m. CEST, down 0.04 percent against the EUR 199.30 prior close dated September 28, 2026. The NYSE context was USD 227.42 on September 28, 2026 at 4:00 p.m. ET.

Danaher stock facts on September 29, 2026

  • Company: Danaher Corporation
  • ISIN: US2358511028
  • Ticker: DHR
  • Primary exchange: NYSE
  • Price Lang & Schwarz as of September 29, 2026, 1:20 p.m. CEST: EUR 199.23
  • Change versus prior close: minus 0.04 percent
  • Prior close Lang & Schwarz (September 28, 2026): EUR 199.30
  • Market capitalization: USD 159.9 billion (as of September 28, 2026)
  • 52-week range: USD 160.93-242.80 (as of September 28, 2026)
  • Sector / Industry: Healthcare / Medical Diagnostics and Research

More news and analyses on Danaher stock

Disclaimer...

en | US2358511028 | DANAHER CORP. | boerse | 70197814 | bgmi